The Zegerid® brand and generic had U.S. sales of approximately $306.7 million MAT for the most recent twelve months ending in May 2016 according to IMS Health.
Dr. Reddy's Laboratories announced today that it has launched Omeprazole and Sodium bicarbonate capsules, 20mg/1100mg and 40mg/1100mg, a therapeutic equivalent generic version of ZEGERID (omeprazole/sodium bicarbonate) capsules in the United States market, having been approved by the U.S. Food & Drug Administration (USFDA).
The Zegerid® brand and generic had U.S. sales of approximately $306.7 million MAT for the most recent twelve months ending in May 2016 according to IMS Health.
Dr. Reddy's Omeprazole and sodium bicarbonate capsules 20 mg/1100 mg and 40 mg/1100 mg are available in bottle count size of 30.
Zegerid is a registered trademark of Santarus, Inc. a wholly owned subsidiary of Salix Pharmaceuticals, Inc.
Dr Reddys Laboratories Ltd is currently trading at Rs. 3584.95, up by Rs. 1.9 or 0.05% from its previous closing of Rs. 3583.05 on the BSE.
The scrip opened at Rs. 3572 and has touched a high and low of Rs. 3610.8 and Rs. 3563.95 respectively. So far 113580(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 61161.93 crore.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016. Last one week high and low of the scrip stood at Rs. 3633 and Rs. 3554.4 respectively.
The promoters holding in the company stood at 25.58 % while Institutions and Non-Institutions held 42.02 % and 32.4 % respectively.
The stock is currently trading above its 200 DMA.
Dr. Reddy's Laboratories announced today that it has launched Omeprazole and Sodium bicarbonate capsules, 20mg/1100mg and 40mg/1100mg, a therapeutic equivalent generic version of ZEGERID (omeprazole/sodium bicarbonate) capsules in the United States market, having been approved by the U.S. Food & Drug Administration (USFDA).The Zegerid® brand and generic had U.S. sales of approximately $306.7 million MAT for the most recent twelve months ending in May 2016 according to IMS Health.
Dr. Reddy's Omeprazole and sodium bicarbonate capsules 20 mg/1100 mg and 40 mg/1100 mg are available in bottle count size of 30.
Zegerid is a registered trademark of Santarus, Inc. a wholly owned subsidiary of Salix Pharmaceuticals, Inc.
Dr Reddys Laboratories Ltd is currently trading at Rs. 3584.95, up by Rs. 1.9 or 0.05% from its previous closing of Rs. 3583.05 on the BSE.
The scrip opened at Rs. 3572 and has touched a high and low of Rs. 3610.8 and Rs. 3563.95 respectively. So far 113580(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 61161.93 crore.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016. Last one week high and low of the scrip stood at Rs. 3633 and Rs. 3554.4 respectively.
The promoters holding in the company stood at 25.58 % while Institutions and Non-Institutions held 42.02 % and 32.4 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment